New Brunswick, NJ (August 22nd, 2023) -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13th. Joaquin Duato, Chairman of the Board and Chief Executive Officer and John Reed, Executive Vice President, Pharmaceuticals, R&D will represent the Company in a session scheduled at 10:10 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
Investor Contact:
investor-relations@its.jnj.com
Media Contact:
media-relations@its.jnj.com